Cost-effectiveness of frontline eltrombopag with immunosuppressive therapy for severe aplastic anemia. [PDF]
Ito S +14 more
europepmc +1 more source
Type B insulin resistance syndrome coexisting with aplastic anemia responsive to early immunosuppressive therapy. [PDF]
Fujisawa T +5 more
europepmc +1 more source
Safety, pharmacokinetics, and preliminary efficacy of hetrombopag in pediatric patients with aplastic anemia: A pilot study. [PDF]
Chang L +11 more
europepmc +1 more source
Role of Interleukin-10 Overexpressing Mesenchymal Stem Cells in Promoting Bone Marrow Functional Recovery in Aplastic Anemia Mice. [PDF]
Mo Q +6 more
europepmc +1 more source
American Society of Hematology 2026 guidelines for the diagnosis and management of severe and very severe acquired aplastic anemia. [PDF]
Scheinberg P +25 more
europepmc +1 more source
[Somatic and immune profiling of chemotherapy-associated aplastic anemia: a comparison with primary aplastic anemia and cancer without aplastic anemia]. [PDF]
Zhang YM, Zhou YX, Zhuang QL, Han B.
europepmc +1 more source
Correlation analysis of cyclosporine A trough concentration with hematological and biochemical parameters: a retrospective study in pediatric aplastic anemia. [PDF]
Xu Q, Mao X, Yun Y, Liu L.
europepmc +1 more source
PTCy-based allo-BMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemia. [PDF]
Dionysiou M +9 more
europepmc +1 more source
A case of vitreoretinal PTLD after HSCT for aplastic anemia.
Zhang Y, Wang X.
europepmc +1 more source
Febrile neutropenia in pediatric acquired aplastic anemia: a 20-year analysis of infections and mortality. [PDF]
Avcu G +8 more
europepmc +1 more source

